Radiopharm Theranostics Files 6-K Report

Ticker: RDPTF · Form: 6-K · Filed: May 19, 2025 · CIK: 1949257

Radiopharm Theranostics Ltd 6-K Filing Summary
FieldDetail
CompanyRadiopharm Theranostics Ltd (RDPTF)
Form Type6-K
Filed DateMay 19, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: reporting, foreign-private-issuer

TL;DR

Radiopharm Theranostics (RPT) filed a 6-K on 5/19/25, confirming it's a foreign private issuer reporting under Form 20-F.

AI Summary

Radiopharm Theranostics Limited filed a Form 6-K on May 19, 2025, reporting information for the month of May 2025. The filing indicates the company is a foreign private issuer and will file annual reports under Form 20-F. The company's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.

Why It Matters

This filing provides routine updates for investors and regulators regarding Radiopharm Theranostics' status as a foreign private issuer and its reporting obligations.

Risk Assessment

Risk Level: low — This filing is a routine administrative report and does not contain new material financial or operational information that would typically increase risk.

Key Players & Entities

  • Radiopharm Theranostics Limited (company) — Registrant
  • 001-41621 (company) — Commission File Number
  • Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (company) — Principal executive office address
  • Form 20-F (company) — Annual report form
  • May 2025 (date) — Reporting period
  • 20250519 (date) — Filing date

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose of this Form 6-K filing is to report information for the month of May 2025 and to confirm Radiopharm Theranostics Limited's status as a foreign private issuer that files annual reports under Form 20-F.

What is the Commission File Number for Radiopharm Theranostics Limited?

The Commission File Number for Radiopharm Theranostics Limited is 001-41621.

Where is Radiopharm Theranostics Limited's principal executive office located?

Radiopharm Theranostics Limited's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.

Does Radiopharm Theranostics Limited file annual reports under Form 20-F or Form 40-F?

Radiopharm Theranostics Limited files annual reports under cover of Form 20-F.

Is Radiopharm Theranostics Limited furnishing information to the Commission pursuant to Rule 12g3-2(b)?

No, Radiopharm Theranostics Limited is not furnishing information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on May 19, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.